Cirrhosis/Liver Failure News

Exemplar Genetics in partnership with Mayo Clinic launched a new company, Cytotheryx, focused on the development of a high-quality source of human liver cells or hepatocytes for clinical research, according to a press release.

Diabetes and high blood glucose levels among individuals without known diabetes correlated with increased risks for liver cancer and chronic liver disease, according results of a Chinese cohort study.

Every year, Healio Gastroenterology and Liver Disease meets with hepatology and gastroenterology experts to discuss their presentations on the latest research data, therapeutic updates, and recent advocacy programs.

Patients with significantly elevated liver iron were more likely men and older and more likely to consume red meat, according to a recently published study.

A simple, four-component risk score stratified patients with cirrhosis by probability for hepatic encephalopathy, according to results from a recently published study.

Fecal microbial transplant restored antibiotic-associated disruption in microbial diversity and function among a cohort of patients with advanced cirrhosis treated with Xifaxan and lactulose, according to a study published in Hepatology.

Anticoagulant treatment safely and effectively led to partial or complete recanalization of the portal venous system in more than half of patients with cirrhosis, according to recently published study results.

Patients with autoimmune hepatitis without cirrhosis had a similar survival rate as the general population, whereas those with cirrhosis had increased risks for death or liver transplantation, according to recently published data.

SAN FRANCISCO — Periodontal therapy in patients with cirrhosis correlated with improved oral and gut dysbiosis, systemic inflammation, MELD score, cognition and 90-day hospitalizations, according to data presented at The Liver Meeting 2018.

SAN FRANCISCO — In this exclusive video perspective from The Liver Meeting 2018, Monica Konerman, MD, director of the Michigan Medicine NAFLD Clinic, discusses results of a study that found opioid use to be twice as common among patients with chronic liver disease compared with other common chronic diseases.